Literature DB >> 12325030

Broad phenotypic variability in a single pedigree with a novel 1410delC mutation in the PST domain of the PAX6 gene.

Michèle M Sale1, Jamie E Craig, Jacinta C Charlesworth, Liesel M FitzGerald, Isabel M Hanson, Joanne L Dickinson, Sarah J Matthews, Veronica van Heyningen Vv, John H Fingert, David A Mackey.   

Abstract

The PAX6 mutation present in an individual with aniridia was determined and phenotypic features of immediate relatives carrying the same mutation investigated. Mutation analysis revealed a novel single base deletion 1410delC in the PAX6 gene in ten affected individuals. Clinical features ranged from total aniridia to very mild anterior segment findings. Other findings included partial aniridia, iris stromal hypoplasia, keratitis, cataract, glaucoma, optic disc anomalies and foveal hypoplasia. It appears that independent modifying factors may underlie the variability of the different phenotypic features of the PAX6 mutation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325030     DOI: 10.1002/humu.9066

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  13 in total

1.  Homozygous mutations in PXDN cause congenital cataract, corneal opacity, and developmental glaucoma.

Authors:  Kamron Khan; Adam Rudkin; David A Parry; Kathryn P Burdon; Martin McKibbin; Clare V Logan; Zakia I A Abdelhamed; James S Muecke; Narcis Fernandez-Fuentes; Kate J Laurie; Mike Shires; Rhys Fogarty; Ian M Carr; James A Poulter; Joanne E Morgan; Moin D Mohamed; Hussain Jafri; Yasmin Raashid; Ngy Meng; Horm Piseth; Carmel Toomes; Robert J Casson; Graham R Taylor; Michael Hammerton; Eamonn Sheridan; Colin A Johnson; Chris F Inglehearn; Jamie E Craig; Manir Ali
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

Review 2.  Regulation of gene expression by Pax6 in ocular cells: a case of tissue-preferred expression of crystallins in lens.

Authors:  Ales Cvekl; Ying Yang; Bharesh K Chauhan; Kveta Cveklova
Journal:  Int J Dev Biol       Date:  2004       Impact factor: 2.203

3.  A novel mutation of PAX6 in Chinese patients with new clinical features of Peters' anomaly.

Authors:  Xiuhua Jia; Xiangming Guo; Xiaoyun Jia; Xueshan Xiao; Shiqiang Li; Qingjiong Zhang
Journal:  Mol Vis       Date:  2010-04-15       Impact factor: 2.367

4.  Aetiology of congenital and paediatric cataract in an Australian population.

Authors:  M G Wirth; I M Russell-Eggitt; J E Craig; J E Elder; D A Mackey
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

5.  Functional properties of natural human PAX6 and PAX6(5a) mutants.

Authors:  Bharesh K Chauhan; Ying Yang; Kveta Cveklová; Ales Cvekl
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

6.  Mild aniridia phenotype: an under-recognized diagnosis of a severe inherited ocular disease.

Authors:  Claudia Yahalom; Anat Blumenfeld; Karen Hendler; Orly Wussuki-Lior; Michal Macarov; Mordechai Shohat; Samer Khateb
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-30       Impact factor: 3.117

7.  A splice site mutation in the PAX6 gene which induces exon skipping causes autosomal dominant inherited aniridia.

Authors:  Nicole Weisschuh; Bernd Wissinger; Eugen Gramer
Journal:  Mol Vis       Date:  2012-03-29       Impact factor: 2.367

8.  Cataract development in Norwegian patients with congenital aniridia.

Authors:  Ulla Edén; Neil Lagali; Anette Dellby; Tor P Utheim; Ruth Riise; Xiangjun Chen; Per Fagerholm
Journal:  Acta Ophthalmol       Date:  2013-07-04       Impact factor: 3.761

9.  Novel mutations of FRMD7 in Chinese patients with congenital motor nystagmus.

Authors:  Xiuhua Jia; Xiang Zhu; Qigen Li; Xiaoyun Jia; Shiqiang Li; Xiangming Guo
Journal:  Mol Med Rep       Date:  2017-06-20       Impact factor: 2.952

10.  Cloning and characterization of canine PAX6 and evaluation as a candidate gene in a canine model of aniridia.

Authors:  Linda S Hunter; Duska J Sidjanin; Manuel Villagrasa Hijar; Jennifer L Johnson; Ewen Kirkness; Gregory M Acland; Gustavo D Aguirre
Journal:  Mol Vis       Date:  2007-03-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.